Science Explorer Interactive view Map
Company · Incheon · South Korea

Celltrion (South Korea)

celltrion.comROR OpenAlex
Research works
103
▲ 80% vs 2013–17
Citations
1.5k
15.1 per fractional work
Top-10% rate
9.4%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Celltrion (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.54× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.82× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 25.35× its world share, 9 worksImmunology and Micro…Neuroscience: 0.20× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.10× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.21× its world share, 0 worksChemistryEngineering: 0.02× its world share, 0 worksEngineeringMathematics: 1.51× its world share, 1 worksMathematicsHealth Professions: 0.03× its world share, 0 worksHealth ProfessionsMedicine: 1.88× its world share, 12 worksMedicineVeterinary: 10.66× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 9.32× its world share, 7 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 25.4×. Every wedge is a field page.

Which keywords describe research at Celltrion (South Korea)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Biopharmaceuticals, Immunogenicity, Bioanalytical Methods, Biosimilars, Quality of Life, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Monoclonal Antibodies9▲ 285×3 topics
  2. Biopharmaceuticals7▲ 406×2 topics
  3. Immunogenicity7▲ 484×2 topics
  4. Bioanalytical Methods7▲ 1026×1 topic
  5. Biosimilars7▲ 1026×1 topic
  6. Quality of Life5▲ 9.2×3 topics
  7. Cost-effectiveness Analysis4▲ 139×1 topic
  8. Health Utility Measures4▲ 139×1 topic
  9. Epidemiology3▲ 2.2×15 topics
  10. Drug Development Costs3▲ 302×1 topic
  11. Generic Drugs3▲ 302×1 topic
  12. Inflammatory Bowel Disease2▲ 64×4 topics
  13. Genetics2▲ 8.2×3 topics
  14. Pathogenesis2▲ 12×5 topics
  15. Crohn's Disease2▲ 65×1 topic
  16. Ulcerative Colitis2▲ 114×1 topic
  17. Therapeutic Antibodies2▲ 72×2 topics
  18. Antibody Engineering2▲ 85×1 topic
  19. Chemotherapy2▲ 6.7×7 topics
  20. Fc Receptors2▲ 85×1 topic
  21. Glycosylation2▲ 43×2 topics
  22. Autoantibodies1▲ 18×3 topics
  23. Inflammation1▲ 1.75×7 topics
  24. PET Imaging1▲ 22×3 topics
  25. Targeted Therapy1▲ 17×4 topics
  26. Cancer Treatment1▲ 14×2 topics
  27. Radioimmunotherapy1▲ 110×1 topic
  28. Radiopharmaceuticals1▲ 110×1 topic
  29. Breast Cancer1▲ 12×2 topics
  30. Clinical Trials1▲ 4.4×3 topics
  31. Cytokines1▲ 11×4 topics
  32. Monoclonal Antibody1▲ 56×2 topics

Which research topics does Celltrion (South Korea) publish most on?

By volume in 2022–2025: Biosimilars and Bioanalytical Methods, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Inflammatory Bowel Disease.

Biosimilars and Bioanaly…7Biosimilars and Bioanalytical Methods: 7 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 4 fractional worksPharmaceutical Economics and Policy: 3 fractional worksInflammatory Bowel Disease: 2 fractional worksMonoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksRheumatoid Arthritis Research and Therapies: 1 fractional worksPharmaceutical studies and practices: 1 fractional works
ImmunologyEconomics and EconometricsGeneticsRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biosimilars and Bioanalytical Methods Immunology 7 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  3. 3 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
  4. 4 Inflammatory Bowel Disease Genetics 2 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  6. 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 HER2/EGFR in Cancer Research Oncology 1 works
  8. 8 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  9. 9 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.1%not open46.9%

World: 28% of research is openly available.

with international co-authors41.7%domestic only58.3%

World: 19% is written across borders.

How has Celltrion (South Korea)'s research output changed?

Output in 2018–2022 was 80% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Incheon

All research institutions in Incheon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.